Therefore, it is speculated that MMB can not only decrease the number of mast cells, but also regulate mast cell function by inhibiting the phosphorylation of STAT3, STAT5 in skin lesions. The gene discussed is STAT5A; the disease is medullomyoblastoma with myogenic differentiation.